CD4 and rheumatoid arthritis: Furthermore, 1,25 (OH)2D3 can reduce the expression of inflammatory factors such as IL-17A, IL-17F, and IL-22, and decrease the number of CD4+ T cells and memory CD4+ cells in stimulated peripheral blood mononuclear cells from treatment-naive patients with early rheumatoid arthritis (Colin et al., 2010).